blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3122375

EP3122375 - BREAST AND OVARIAN CANCER VACCINES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.01.2022
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  29.01.2021
FormerGrant of patent is intended
Status updated on  14.09.2020
FormerExamination is in progress
Status updated on  25.08.2020
FormerGrant of patent is intended
Status updated on  15.04.2020
FormerExamination is in progress
Status updated on  13.02.2019
FormerRequest for examination was made
Status updated on  30.12.2016
FormerThe international publication has been made
Status updated on  09.12.2016
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
University of Washington through its Center for Commercialization
4311 11th Avenue NE
Suite 500
Seattle, WA 98105 / US
[2017/05]
Inventor(s)01 / DISIS, Mary, L.
17850 SE 192nd Drive
Renton, WA 98058 / US
02 / CECIL, Denise
19224 15th Avenue NW
Shoreline, WA 98177 / US
03 / SLOTA, Meredith
c/o University of Washington
4545 Roosevelt Way NE
Suite 400
Seattle, WA 98105 / US
 [2017/08]
Former [2017/05]01 / DISIS, Mary, L.
17850 SE 192nd Drive
Renton, WA 98058 / US
02 / CECIL, Denise
19224 15th Avenue NW
Shoreline, WA 98177 / US
03 / SLOTA, Meredith
1711 25th Avenue
Apt. 1
Seattle, WA 98122 / US
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2021/09]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2017/05]Roques, Sarah Elizabeth
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date15768124.827.03.2015
[2017/05]
WO2015US23161
Priority number, dateUS201461972176P28.03.2014         Original published format: US 201461972176 P
[2017/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015149016
Date:01.10.2015
Language:EN
[2015/39]
Type: A2 Application without search report 
No.:EP3122375
Date:01.02.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 01.10.2015 takes the place of the publication of the European patent application.
[2017/05]
Type: B1 Patent specification 
No.:EP3122375
Date:03.03.2021
Language:EN
[2021/09]
Search report(s)International search report - published on:US28.01.2016
(Supplementary) European search report - dispatched on:EP20.03.2018
ClassificationIPC:A61K39/00, A61K48/00, C12N15/00
[2017/05]
CPC:
A61K39/0011 (EP,US); A61K39/001103 (EP,US); A61K39/001106 (EP,US);
A61K39/001129 (EP,US); A61K39/00115 (EP,US); A61K39/001152 (EP,US);
A61P15/14 (EP); A61P35/00 (EP); A61P37/04 (EP);
C07K14/4702 (US); C07K14/705 (US); C07K14/70567 (US);
C07K14/70596 (US); C07K14/71 (US); C12N15/62 (US);
C12N9/104 (EP,US); C12Y203/02 (EP,US); A61K2039/53 (EP,US);
A61K2039/54 (US); A61K2039/572 (EP,US); A61K48/00 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/05]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:IMPFUNGEN GEGEN BRUST- UND EIERSTOCKKREBS[2017/05]
English:BREAST AND OVARIAN CANCER VACCINES[2017/05]
French:VACCINS CONTRE LE CANCER DU SEIN ET DES OVAIRES[2017/05]
Entry into regional phase04.10.2016National basic fee paid 
04.10.2016Search fee paid 
04.10.2016Designation fee(s) paid 
04.10.2016Examination fee paid 
Examination procedure04.10.2016Examination requested  [2017/05]
04.10.2016Date on which the examining division has become responsible
19.10.2018Amendment by applicant (claims and/or description)
18.02.2019Despatch of a communication from the examining division (Time limit: M04)
27.03.2019Reply to a communication from the examining division
08.07.2019Despatch of a communication from the examining division (Time limit: M06)
07.01.2020Reply to a communication from the examining division
16.04.2020Communication of intention to grant the patent
18.08.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.09.2020Communication of intention to grant the patent
22.01.2021Fee for grant paid
22.01.2021Fee for publishing/printing paid
22.01.2021Receipt of the translation of the claim(s)
Opposition(s)06.12.2021No opposition filed within time limit [2022/06]
Fees paidRenewal fee
27.03.2017Renewal fee patent year 03
27.03.2018Renewal fee patent year 04
27.03.2019Renewal fee patent year 05
27.03.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.03.2015
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
MT03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
TR03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
[2024/41]
Former [2024/29]HU27.03.2015
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
TR03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2024/22]HU27.03.2015
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
MK03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2023/30]HU27.03.2015
AL03.03.2021
AT03.03.2021
CY03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2023/27]HU27.03.2015
AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/23]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/13]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SI03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
PT05.07.2021
Former [2022/10]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
PT05.07.2021
Former [2022/09]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SK03.03.2021
SM03.03.2021
LU27.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2022/07]AL03.03.2021
AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
MC03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2021/51]AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
GR04.06.2021
IS03.07.2021
PT05.07.2021
Former [2021/50]AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RO03.03.2021
RS03.03.2021
SK03.03.2021
SM03.03.2021
BG03.06.2021
GR04.06.2021
PT05.07.2021
Former [2021/48]AT03.03.2021
CZ03.03.2021
EE03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RS03.03.2021
SM03.03.2021
BG03.06.2021
GR04.06.2021
Former [2021/46]AT03.03.2021
HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RS03.03.2021
SM03.03.2021
BG03.06.2021
GR04.06.2021
Former [2021/39]HR03.03.2021
LT03.03.2021
LV03.03.2021
PL03.03.2021
RS03.03.2021
BG03.06.2021
GR04.06.2021
Former [2021/37]HR03.03.2021
LT03.03.2021
LV03.03.2021
RS03.03.2021
BG03.06.2021
GR04.06.2021
Former [2021/36]HR03.03.2021
LT03.03.2021
BG03.06.2021
GR04.06.2021
Former [2021/35]HR03.03.2021
LT03.03.2021
Former [2021/33]LT03.03.2021
Documents cited:Search[A]WO0050590  (CURAGEN CORP [US], et al);
 [A]WO0102556  (MAX DELBRUECK CENTRUM [DE], et al);
 [I]WO2008073660  (UNIV WASHINGTON [US], et al);
International search[A]US2007083334  (MINTZ LIAT [US], et al);
 [XYA]US2009170767  (KARUMANCHI S ANANTH [US], et al);
 [A]US2010150918  (KUFER PETER [DE], et al);
 [A]US2011008347  (ULLRICH AXEL [DE], et al);
 [A]US2012128584  (TOGASHI AKIRA [JP], et al);
 [YA]US2012135033  (WALLECHA ANU [US]);
 [A]US2013034566  (SHIBA YASUHIRO [JP], et al);
by applicantUS3625214
 US4270537
 US4469863
 US4596556
 US4789734
 US4790824
 US4886499
 US4897268
 US4906474
 US4925673
 US4940460
 US4941880
 US5015235
 US5034506
 US5064413
 US5075109
 US5141496
 US5190521
 US5216141
 US5235033
 US5312335
 US5328483
 US5334144
 US5339163
 US5383851
 US5386023
 US5417662
 US5466220
 US5480381
 US5503627
 US5520639
 US5527288
 US5569189
 US5599302
 US5602240
 WO9713537
 US5637684
 US5644048
 US5649912
 WO9737705
 US5704911
 US5811128
 US5814344
 US5820883
 US5853763
 US5893397
 WO9934850
 US5928647
 US5942252
 US5993412
 WO0050590
 WO0102556
 US2007083334
 WO2008073660
 US2009170767
 US2010150918
 US2011008347
 US2012128584
 US2012135033
 US2013034566
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.